NMC Health has gone into administration. Here’s what that means for those who own the shares

NMC Health shares were suspended in February. Now the company’s gone into administration and there are lessons to be learnt.

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

On Thursday afternoon, shortly before the UK stock market closed for the Easter break, NMC Health (LSE: NMCannounced it had appointed administrators. This comes after the company was embroiled in an accounting scandal late last year, and NMC Health shares were suspended from trading on 27 February.

Here, I’ll look at what this means for those who own NMC shares. I’ll also highlight two red flags that could have helped investors see this coming.

NMC Health in administration

When a company goes into administration, it’s taken under control by a licensed insolvency practitioner (the administrator). The ultimate objective of the administrator is to decide whether the company has the potential to trade successfully again – possibly after financial restructuring – or whether its problems are insurmountable.

If the latter, it will need to be ‘liquidated’, which means dissolved completely. While in administration, the company can continue to operate. However, it will have protection from creditors, who may be threatening legal action over outstanding debt.

In NMC’s case, Abu Dhabi Commercial Bank – which is owed almost $1bn by the company – pushed for administration. It feared NMC would be unable to pay employees in the months ahead and that the whole company may collapse.

Bad news for shareholders

For company shareholders, going into administration is generally very bad news. This is due to the fact that, if the administration involves a sale of all or part of the company’s assets to pay off creditors, shareholders are last to receive anything. They rank behind bond holders in terms of priority. Most of the time, they end up receiving nothing.

Looking at NMC Health, it’s too early to know if shareholders will get anything back. However, my personal view is it’s unlikely. I say this because, last month, investigators discovered the company had undisclosed debt of $4bn, taking its total debt to over $6.5bn. This is far higher than the assets and equity on the company’s books at 30 June.

NMC Health shares: two red flags

Looking back, there were certainly a few red flags here that could have helped investors avoid this mess.

For a start, there was the short attack by research firm Muddy Waters in December. In a highly critical 34-page report, Muddy Waters said it had “serious doubts” about NMC’s financial statements and that it believed NMC had “manipulated its balance sheet to understate debt.”

Whenever a company gets attacked like this, it pays to be very careful. This is because you can be sure the shorter has done their research. Looking back, Muddy Waters’ research was on the mark, as NMC understated its debt massively.

Secondly, earlier this year, a number of insiders at the company, including founder and chairman Bavaguthu Raghuram Shetty and vice-chairman Khalifa Al Muhairi, offloaded a huge number of NMC Health shares. Between them, they sold nearly £200m worth of shares in January and February.

Insider selling is not always a bearish signal. There are plenty of legitimate reasons for insiders to sell shares. However, in this case, the selling certainly didn’t look good, given the doubts over the group’s balance sheet.

Had investors sold NMC Health shares on spotting these red flags, they may have been able to protect their capital.

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Edward Sheldon has no position in any shares mentioned. The Motley Fool UK owns shares of and has recommended NMC Health. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

3 of my top FTSE 250 stocks to consider buying before April

Buying undervalued UK shares can be a great way to generate long-term wealth. Here, Royston Wild reveals a handful on…

Read more »

Ice cube tray filled with ice cubes and three loose ice cubes against dark wood.
Investing Articles

Just released: our 3 top income-focused stocks to buy before April [PREMIUM PICKS]

Our goal here is to highlight some of our past recommendations that we think are of particular interest today, due…

Read more »

Investing Articles

Is this the best chance to buy cheap FTSE 100 shares in a generation?

I want to buy shares when they're cheap, and sell... never, just keep taking the dividends. And the FTSE 100…

Read more »

Man putting his card into an ATM machine while his son sits in a stroller beside him.
Investing Articles

Could NatWest shares be 2024’s number one buy for passive income?

For those of us looking to earn some long-term passive income, how does NatWest's 7% dividend yield sound? It sounds…

Read more »

Investing Articles

£12K in savings? Here’s how I could turn that into £13K annual passive income

This Fool explains how investing a lump sum can help her build a passive income stream to enjoy in her…

Read more »

Aerial shot showing an aircraft shadow flying over an idyllic beach
Investing Articles

Here’s why Rolls-Royce shares are now set to fly over the £4 mark

Once again, Rolls-Royce shares are crushing the FTSE 100. Should I add to my holding of this stock at the…

Read more »

Investing Articles

1 under the radar FTSE 100 AI stock investors should consider buying

Our writer explains why this FTSE 100 pick could be a shrewd investment with its established experience of using AI…

Read more »

Investing Articles

Does the beaten-down Diageo share price make it a no-brainer buy?

Harvey Jones spent years waiting for the Diageo share price to look like good value, before finally buying it in…

Read more »